The global monoclonal antibodies (mAbs) market is currently experiencing substantial growth and is projected to maintain a strong upward trajectory over the next decade. Valued at approximately U...
Introduction
In the rapidly advancing world of biotechnology, monoclonal antibodies (mAbs) have emerged as one of the most transformative therapeutic tools in medicine. From cancer immunotherapy t...